Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature.

de Jonge P, Rosmalen JG, Kema IP, Doornbos B, van Melle JP, Pouwer F, Kupper N.

Neurosci Biobehav Rev. 2010 Sep;35(1):84-90. doi: 10.1016/j.neubiorev.2009.11.025. Epub 2009 Dec 3. Review.

PMID:
19962401
2.

Depression and coronary artery disease.

Frasure-Smith N, Lespérance F.

Herz. 2006 Dec;31 Suppl 3:64-8. Review.

PMID:
17575807
3.

Depressive symptoms predict heart rate recovery after exercise treadmill testing in patients with coronary artery disease: results from the Psychophysiological Investigation of Myocardial Ischemia study.

Hughes JW, York KM, Li Q, Freedland KE, Carney RM, Sheps DS.

Psychosom Med. 2008 May;70(4):456-60. doi: 10.1097/PSY.0b013e31816fcab3. Epub 2008 Apr 23.

PMID:
18434491
4.

Depression and coronary artery atherosclerosis and reactivity in female cynomolgus monkeys.

Shively CA, Williams JK, Laber-Laird K, Anton RF.

Psychosom Med. 2002 Sep-Oct;64(5):699-706.

PMID:
12271100
5.

Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.

McCaffery JM, Frasure-Smith N, Dubé MP, Théroux P, Rouleau GA, Duan Q, Lespérance F.

Psychosom Med. 2006 Mar-Apr;68(2):187-200. Review.

PMID:
16554382
6.

Psychosocial factors in the development of coronary artery disease.

Strike PC, Steptoe A.

Prog Cardiovasc Dis. 2004 Jan-Feb;46(4):337-47. Review.

PMID:
14961456
7.

The role of serotonin in depression and clotting in the coronary artery disease population.

Sanner JE, Frazier L.

J Cardiovasc Nurs. 2011 Sep-Oct;26(5):423-9. doi: 10.1097/JCN.0b013e3182076a81. Review.

PMID:
21372736
8.

Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease.

Kwaijtaal M, van der Ven AJ, van Diest R, Bruggeman CA, Bär FW, Calandra T, Appels A, Sweep FC.

Psychosom Med. 2007 Jan;69(1):68-73.

PMID:
17244850
9.

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.

Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF.

Psychosom Med. 2004 May-Jun;66(3):305-15. Review.

PMID:
15184688
10.

Preadolescents' somatic and cognitive-affective depressive symptoms are differentially related to cardiac autonomic function and cortisol: the TRAILS study.

Bosch NM, Riese H, Dietrich A, Ormel J, Verhulst FC, Oldehinkel AJ.

Psychosom Med. 2009 Nov;71(9):944-50. doi: 10.1097/PSY.0b013e3181bc756b. Epub 2009 Oct 15.

PMID:
19834052
11.

Beneficial effect(s) of n-3 fatty acids in cardiovascular diseases: but, why and how?

Das UN.

Prostaglandins Leukot Essent Fatty Acids. 2000 Dec;63(6):351-62. Review. Erratum in: Prostaglandins Leukot Essent Fatty Acids 2001 Jan;64(1):74.

PMID:
11133172
12.

Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.

van Melle JP, de Jonge P, van den Berg MP, Pot HJ, van Veldhuisen DJ.

Drugs. 2006;66(16):2095-107.

PMID:
17112303
13.

Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms.

Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, Storti C, Falcone C.

Int J Mol Med. 2009 Dec;24(6):813-8.

PMID:
19885623
14.

Unipolar depression and the progression of coronary artery disease: toward an integrative model.

Ormel J, de Jonge P.

Psychother Psychosom. 2011;80(5):264-74. doi: 10.1159/000323165. Epub 2011 Jun 1.

PMID:
21646821
15.

Mood and neuropsychological function in depression: the role of corticosteroids and serotonin.

McAllister-Williams RH, Ferrier IN, Young AH.

Psychol Med. 1998 May;28(3):573-84. Review.

PMID:
9626714
16.

Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function.

Pizzi C, Manzoli L, Mancini S, Costa GM.

Eur Heart J. 2008 May;29(9):1110-7. doi: 10.1093/eurheartj/ehn137. Epub 2008 Apr 8.

PMID:
18400765
17.

Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications.

Parissis JT, Fountoulaki K, Filippatos G, Adamopoulos S, Paraskevaidis I, Kremastinos D.

Int J Cardiol. 2007 Mar 20;116(2):153-60. Epub 2006 Jul 5. Review.

PMID:
16822560
18.

The role of some new factors in the pathophysiology of depression and cardiovascular disease: overview of recent research.

Kitzlerová E, Anders M.

Neuro Endocrinol Lett. 2007 Dec;28(6):832-40. Review.

PMID:
18063922
19.

A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.

Stapelberg NJ, Neumann DL, Shum DH, McConnell H, Hamilton-Craig I.

Aust N Z J Psychiatry. 2011 May;45(5):351-69. doi: 10.3109/00048674.2011.570427. Review.

PMID:
21500954
20.

Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Gold SM, Irwin MR.

Neurol Clin. 2006 Aug;24(3):507-19.

PMID:
16877121

Supplemental Content

Support Center